Fundz

Voltron Therapeutics, Inc. reported raising $300,000 in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEJun 16, 2022$300K of $5M raised

Amount Raised

$300,000

$300,000 sold, per SEC Form D (first sale Jun 16, 2022)

Round Type

Seed

New YorkBiotechnologyHealthcare

Quick answer

Voltron Therapeutics, Inc. raised $300,000 in a Seed round, dated June 16, 2022. Voltron Therapeutics, Inc. is based in New York, New York, United States.

How much did Voltron Therapeutics, Inc. raise?
Voltron Therapeutics, Inc. raised $300,000 in a Seed round on June 16, 2022.
What does Voltron Therapeutics, Inc. do?
Voltron Therapeutics, Inc. is improving cell mediated responses to combat infectious diseases, such as COVID-19 and specific forms of cancers, using the advanced and proprietary VaxCelerate™ Self-Assembling Vaccine..
Where is Voltron Therapeutics, Inc. based and how big is it?
Voltron Therapeutics, Inc. is based in New York, New York, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Voltron Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Elevation Oncology raised $50M (Debt Financing) on July 28, 2022.
  • SCA Health raised $142K (Pre-Seed) on July 27, 2022.
  • Biofrontera raised $7.1M on July 27, 2022.
  • MIRA Pharmaceuticals raised $625K (Seed) on July 22, 2022.
  • Enveric Biosciences raised $8.6M on July 22, 2022.
  • Renibus Therapeutics raised $15M on July 15, 2022.

Who to call at Voltron Therapeutics, Inc., and when

A new round usually means Voltron Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Voltron Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Voltron Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Voltron Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Voltron Therapeutics, Inc.

Location

12 E 49TH STREET

New York, New York, United States

About

Voltron Therapeutics, Inc. is improving cell mediated responses to combat infectious diseases, such as COVID-19 and specific forms of cancers, using the advanced and proprietary VaxCelerate™ Self-Assembling Vaccine Design developed by specialists at the Massachusetts General Hospital (MGH) and the Vaccine & Immunotherapy Center. Voltron has an exclusive license to this technology from MGH.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Voltron Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Voltron Therapeutics, Inc.'s next move

See what Strategic adds

Voltron Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.